Alzheimer's disease (AD) profoundly affects brain tissue and network structures. Analyzing the topological properties of these networks helps to understand the progression of the disease. Most studies focus on single-scale brain networks, but few address multiscale brain networks. In this study, the renormalization group approach was applied to rescale the gray matter brain networks of AD patients and cognitively normal (CN) into three scales: the original, once-renormalized, and twice-renormalized networks. Based on the fractal property of these networks at different scales, a novel framework for classifying Alzheimer's disease using fractal and renormalization group was proposed. We integrated the fractal metrics across different scales to create fused feature vectors, which served as inputs for the classification framework aimed at diagnosing Alzheimer's disease. The experimental result indicates that the original and once-renormalized networks of both CN and AD exhibit the fractal property. The classification framework performed best when using the fused feature vector, including the average connection ratio of the original and once-renormalized networks. Using the fused feature vector of the average connection ratio, the One-Dimensional Convolution Neural Network model achieved an accuracy of 92.59% and an F1 score of 91.19%. This marks an improvement of approximately 10% in accuracy and 5% in F1 score compared to results using feature fusion of the average degree, average path length, and clustering coefficient.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainres.2024.149373DOI Listing

Publication Analysis

Top Keywords

alzheimer's disease
16
classification framework
12
fractal property
12
brain networks
12
original once-renormalized
12
fused feature
12
feature vectors
8
networks
8
renormalization group
8
once-renormalized networks
8

Similar Publications

Age-related cognitive impairment and dementia pose a significant global health, social, and economic challenge. While Alzheimer's disease (AD) has historically been viewed as the leading cause of dementia, recent evidence reveals the considerable impact of vascular cognitive impairment and dementia (VCID), which now accounts for nearly half of all dementia cases. The Mediterranean diet-characterized by high consumption of fruits, vegetables, whole grains, fish, and olive oil-has been widely recognized for its cardiovascular benefits and may also reduce the risk of cognitive decline and dementia.

View Article and Find Full Text PDF

Microglial polarization and ferroptosis are important pathological features in Alzheimer's disease (AD). Ghrelin, a brain-gut hormone, has potential neuroprotective effects in AD. This study aimed to explore the potential mechanisms by which ghrelin regulates the progression of AD, as well as the crosstalk between microglial polarization and ferroptosis.

View Article and Find Full Text PDF

The long-term health of former athletes with a history of multiple concussions and/or repetitive head impact (RHI) exposure has been of growing interest among the public. The true proportion of dementia cases attributable to neurotrauma and the neurobehavioral profile/sequelae of multiple concussion and RHI exposure among athletes has been difficult to determine. Across three exposure paradigms (i.

View Article and Find Full Text PDF

Background: Edible insects are used for consumption and traditional medicine due to their rich bioactive compounds. This study examined the bioactive compounds and inhibitory effects of crude extracts from Bombyx mori and Omphisa fuscidentalis on α-glucosidase, α-amylase, acetylcholinesterase (AChE), and tyrosinase. Fatty acids, including n-hexadecanoic acid and oleic acid, were identified in the extracts and evaluated for their inhibitory potential against the enzymes in vitro and in silico.

View Article and Find Full Text PDF

From Antipsychotic to Neuroprotective: Computational Repurposing of Fluspirilene as a Potential PDE5 Inhibitor for Alzheimer's Disease.

J Comput Chem

January 2025

Centre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, New South Wales, Australia.

Phosphodiesterase 5 (PDE5) inhibitors have shown great potential in treating Alzheimer's disease by improving memory and cognitive function. In this study, we evaluated fluspirilene, a drug commonly used to treat schizophrenia, as a potential PDE5 inhibitor using computational methods. Molecular docking revealed that fluspirilene binds strongly to PDE5, supported by hydrophobic and aromatic interactions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!